Management of the waiting list for cadaveric kidney transplants: Report of a survey and recommendations by the Clinical Practice Guidelines Committee of the American Society of Transplantation

The Clinical Practice Guidelines Committee of the American Society of Transplantation developed a survey to review the policies of kidney transplant programs in the United States with respect to the management of the steadily expanding waiting list for cadaveric kidneys. The survey was sent to 287 c...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American Society of Nephrology 2002-02, Vol.13 (2), p.528-535
Main Authors: DANOVITCH, Gabriel M, HARIHARAN, Sundaram, PIRSCH, John D, RUSH, David, ROTH, David, RAMOS, Emilio, STARLING, Randall C, CANGRO, Chuck, WEIR, Mattthew R
Format: Article
Language:English
Subjects:
Biological and medical sciences
Cadaver
Combined surgery. Multiple transplantations
Coronary Disease - epidemiology
Data Collection
Follow-Up Studies
Humans
Kidney Transplantation
Medical sciences
Pancreas Transplantation
Population Surveillance
Risk Factors
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Waiting Lists
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The Clinical Practice Guidelines Committee of the American Society of Transplantation developed a survey to review the policies of kidney transplant programs in the United States with respect to the management of the steadily expanding waiting list for cadaveric kidneys. The survey was sent to 287 centers, and 192 (67%) responded. The survey indicated that regular follow-up monitoring, most frequently on an annual basis, is required by the majority (71%) of programs. Patients considered to be at high risk and candidates for combined kidney-pancreas transplantation may be monitored more frequently. Annual screening for coronary artery disease is typically required for asymptomatic patients considered to be at high risk for covert disease. Noninvasive techniques are typically used, and a designated cardiologist is usually available to the transplant program. The dialysis nephrologist or the potential transplant recipient is expected to inform the transplant program of intercurrent events that may affect transplant candidacy. Standard health maintenance screening is required, together with the routine updating of serologic and other blood tests that may be relevant to the posttransplant course. Smaller transplant programs (
ISSN:1046-6673
1533-3450
DOI:10.1681/ASN.V132528